Jinlong Zhang

Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial

Shipo Wu, Jianying Huang, Zhe Zhang et al. · The Lancet Infectious Diseases · 2021 · 291 citations · Full text

A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge

Shipo Wu, Gongxun Zhong, Jun Zhang et al. · Nature Communications · 2020 · 284 citations · Full text

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial

Fengcai Zhu, Lihua Hou, Jingxin Li et al. · The Lancet · 2015 · 187 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +7

Whole genome sequencing revealed host adaptation-focused genomic plasticity of pathogenic Leptospira

Yinghua Xu, Yongzhang Zhu, Yuezhu Wang et al. · Scientific Reports · 2016 · 118 citations · Full text

A potent neutralizing human antibody reveals the N-terminal domain of the Spike protein of SARS-CoV-2 as a site of vulnerability

Xiangyang Chi, Renhong Yan, Jun Zhang et al. · 2020 · 52 citations · Full text

New Vulnerable Epitope, Viral Pathogenesis, Immunology +18